本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Kura Oncology, Inc

5.89
-0.2800-4.54%
盤後5.890.00000.00%19:37 EDT
成交量:144.94萬
成交額:856.54萬
市值:4.76億
市盈率:-2.92
高:6.16
開:6.08
低:5.82
收:6.17
資料載入中...
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/17

重要事件披露

Form 8-K - Current report
2024/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/09

重要事件披露

Form 8-K - Current report
2024/06/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/02

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

重要事件披露

Form 8-K - Current report
2024/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/15

SEC問詢函

Form CORRESP - Correspondence
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

SEC問詢函

Form CORRESP - Correspondence
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]